FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.

Abstract

Post-transplant lymphoproliferative disease (PTLD) is a major cause of morbidity and mortality following both solid organ and haematopoietic stem cell transplantation. PTLD has a broad range of manifestations with extranodal involvement more common in the abdomen than nodal involvement. Fludeoxyglucose positron emission tomography/CT (FDG-PET/CT) is sensitive and specific to detect PTLD and can upstage or detect occult PTLD compared with conventional CT imaging. As functional imaging, FDG-PET/CT also has a role in monitoring treatment response. In this pictorial essay, we will discuss the role of FDG-PET/CT in the diagnosis and staging of abdominal PTLD and describe the advantages of functional imaging in assessing response to therapy.

DOI: 10.1259/bjr.20150844

Cite this paper

@article{Metser2016FDGPETCTIA, title={FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.}, author={Ur Metser and Glen M Lo}, journal={The British journal of radiology}, year={2016}, volume={89 1057}, pages={20150844} }